Odile has spent most of her career in vaccine development, as a scientist in Africa for nine years, followed by Corporate Clinical Director of airborne vaccines for ten years at Pasteur Mérieux Connaught (Sanofi Pasteur).  She joined EMVI in 2002 as Clinical and Regulatory Director, and from 2005 to 2006, she headed the European and Developing Countries’ Clinical Trial Partnership as Executive Director.

Odile is a member of the Science Board of the Brighton Collaboration, coordinator of the FP7 vaccine infrastructure project TRANSVAC, and a member of the WHO product development group for the measles aerosol project.

Odile is a trained physician who has specialised in the areas of epidemiology, clinical pharmacology, and vaccinology.

The European Vaccine Initiative (EVI) is leading European efforts to develop effective, accessible, and affordable vaccines against diseases of poverty. EVI’s vision is 'a world free of the intolerable burden of diseases of poverty within the coming decades'.